IP Library Patent Application 14175673
Patent Application
App. No. 14/175,673

TRI-MOLECULAR COMPLEXES AND THEIR USE IN DRUG DELIVERY SYSTEMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/175,673
Abstract

This invention relates to macromolecular complexes useful in drug delivery systems, specifically tri-molecular complexes made between a water-soluble polymer and an acid-insoluble polymer in presence of a bridging molecule. In one aspect, the invention relates to a tri-molecular complex comprising gelatin, acrylic acid/methacrylic acid copolymers, and arginine for use in a soft capsule dosage form. In another aspect, the invention is directed to a tri-molecular complex a hydrophilic, film-forming, water-soluble polymer, a second water-soluble polymer, and a bridging molecule, wherein the second water-soluble polymer is less water-soluble than the hydrophilic, film-forming, water-soluble polymer.

Claims (24)

1 . A tri-molecular complex for use in enteric drug delivery systems comprising:

(a) a hydrophilic, film-forming, water-soluble polymer;

(b) an acid-insoluble polymer; and

(c) an amino acid.

2 . The tri-molecular complex according to claim 1 , further comprising an aqueous solvent.

3 . The tri-molecular complex according to claim 1 , further comprising a plasticizer.

4 . The tri-molecular complex according to claim 1 , wherein the amino acid is arginine.

5 . The tri-molecular complex according to claim 1 , wherein the water-soluble polymer is gelatin, the acid-insoluble polymer is acrylate-methacrylate copolymers, and the amino acid is arginine.

6 . The tri-molecular complex according to claim 3 , wherein the plasticizer is selected from the group consisting of glycerin, triethylcitrate, and mixtures thereof.

7 . The tri-molecular complex according to claim 5 , wherein the amount of acrylate-methacrylate copolymers is at least about 25% by weight of the total amount of acrylate-methacrylate copolymers and gelatin.

8 . The tri-molecular complex according to claim 6 , wherein the plasticizer is a mixture of glycerin and triethylcitrate.

9 . The tri-molecular complex according to claim 5 , further comprising glycerin.

10 . A tri-molecular complex for use in controlling the release of a therapeutic or diagnostic agent comprising:

(a) a hydrophilic, film-forming, water-soluble polymer;

(b) acrylate-methacrylate copolymers; and

(c) a bridging molecule,

wherein the acrylate-methacrylate copolymers are less water-soluble than the hydrophilic, film-forming, water-soluble polymer.

11 . A method of preparing the tri-molecular complex according to claim 1 comprising the following steps: (1) suspending the acid-insoluble polymer in an acidic aqueous system with low buffer capacity; (2) mixing the water-soluble polymer with the amino acid; and (3) mixing the product of steps (1) and (2) to yield the tri-molecular complex.

12 . A tri-molecular complex for use in enteric drug delivery systems comprising:

(a) gelatin;

(b) acrylate-methacrylate copolymers; and

(c) arginine,

wherein the tri-molecular complex further comprises glycerin.

13 . The tri-molecular complex according to claim 12 , wherein the amount of acrylate-methacrylate copolymers is at least about 25% by weight of the total amount of acrylate-methacrylate copolymers and gelatin.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Nov 18, 2021
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
To: PHARMACEUTICS INTERNATIONAL, INC.
Reel/Frame 058155/0054 →
SECURITY INTEREST Recorded Aug 31, 2016
From: PHARMACEUTICS INTERNATIONAL, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
Reel/Frame 039885/0722 →